 rates of mortality,
paraplegia, and renal failure. Thoracic endovascular aortic repair (TEVAR) has revolutionized treatment of the DTA and
has largely supplanted open repair because of lower morbidity and mortality. These Society for Vascular Surgery Practice
Guidelines are applicable to the use of TEVAR for descending thoracic aortic aneurysm (TAA) as well as for other rarer
pathologic processes of the DTA. Management of a